A Dose Escalation and Safety Study of I5NP to Prevent Acute Kidney Injury (AKI) in Patients at High Risk of AKI Undergoing Major Cardiovascular Surgery (QRK.004)
This study has been terminated.
(Lack of an available patient population)
First Posted: May 23, 2008
Last Update Posted: November 16, 2010
Information provided by: